Jiakang Ma

Henan Key Laboratory Of Cancer Epigenetics
Luoyang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Development and Validation of Salivary Exosomal Tri-RNA Liquid Biopsy in Esophageal Carcinoma: A Multicenter Study.

Development and Validation of Salivary Exosomal Tri-RNA Liquid Biopsy in Esophageal Carcinoma: A Multicenter Study.

Journal: JCO precision oncology

Published: June 29, 2026

Heterogeneous SPP1-expressing esophageal cancer cells license immunotherapy resistance by organizing an immunosuppressive niche.

Heterogeneous SPP1-expressing esophageal cancer cells license immunotherapy resistance by organizing an immunosuppressive niche.

Journal: Neoplasia (New York, N.Y.)

Published: February 23, 2026

Extracellular Vesicles as Immunotherapeutic Mediators in Gastrointestinal Cancers and Diseases: From Mechanisms to Clinical Translation.

Extracellular Vesicles as Immunotherapeutic Mediators in Gastrointestinal Cancers and Diseases: From Mechanisms to Clinical Translation.

Journal: Clinical pharmacology and therapeutics

Published: December 20, 2025

Integrative Genomic and Single-Cell Insights Into Efferocytosis-Mediated Immune Regulation in Clear Cell Renal Cell Carcinoma.

Integrative Genomic and Single-Cell Insights Into Efferocytosis-Mediated Immune Regulation in Clear Cell Renal Cell Carcinoma.

Journal: Mediators of inflammation

Published: September 12, 2025

Integrative Genomic and Single-Cell Insights Into Efferocytosis-Mediated Immune Regulation in Clear Cell Renal Cell Carcinoma.

Integrative Genomic and Single-Cell Insights Into Efferocytosis-Mediated Immune Regulation in Clear Cell Renal Cell Carcinoma.

Journal: Mediators of inflammation

Published: September 12, 2025

Advancing immunotherapy for esophageal cancer: decoding the roles of PD-L1, TME, and tumor-intrinsic biomarkers.

Advancing immunotherapy for esophageal cancer: decoding the roles of PD-L1, TME, and tumor-intrinsic biomarkers.

Journal: Frontiers in immunology

Published: August 04, 2025

Single-cell and multi-omics integrative modeling identifies mitochondrial gene HSPE1 as a therapeutic target in osteosarcoma.

Single-cell and multi-omics integrative modeling identifies mitochondrial gene HSPE1 as a therapeutic target in osteosarcoma.

Journal: Journal of translational medicine

Published: July 27, 2025

Circular RNAs and immunotherapy in retinoblastoma: emerging biomarkers and precision therapeutic strategies.

Circular RNAs and immunotherapy in retinoblastoma: emerging biomarkers and precision therapeutic strategies.

Journal: Frontiers in immunology

Published: July 17, 2025

Single-Cell and Multi-Omics-Based Characterization of Gastric Cancer Identifies TPP1 as a Potential Target for Gastric Cancer Progression and Treatment.

Single-Cell and Multi-Omics-Based Characterization of Gastric Cancer Identifies TPP1 as a Potential Target for Gastric Cancer Progression and Treatment.

Journal: Oncology research

Published: July 10, 2025

Integrated Genomic and Functional Characterization of Palmitoylation in Clear Cell Renal Cell Carcinoma.

Integrated Genomic and Functional Characterization of Palmitoylation in Clear Cell Renal Cell Carcinoma.

Journal: Human mutation

Published: June 08, 2025

Sex-based responses to immunotherapy in esophageal cancer: insights from a meta-analysis.

Sex-based responses to immunotherapy in esophageal cancer: insights from a meta-analysis.

Journal: BMC gastroenterology

Published: April 30, 2025

Integrative Genomic and Single-Cell Insights Into Efferocytosis-Mediated Immune Regulation in Clear Cell Renal Cell Carcinoma.

Integrative Genomic and Single-Cell Insights Into Efferocytosis-Mediated Immune Regulation in Clear Cell Renal Cell Carcinoma.

Journal: Mediators of inflammation

Published: January 01, 2025

Showing 1-12 of 13

Last Updated: 09/26/2026